Data quality in the Danish National acute Leukemia Registry: A hematological data resource

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 335-344

  Granfeldt Østgård, Lene Sofie ^a   Nørgaard, Jan Maxwell ^a   Severinsen, Marianne Tang ^b   Sengeløv, Henrik ^c   Friis, Lone ^d   Jensen, Morten Krogh ^e   Nielsen, Ove Juul ^c   Nørgaard, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myeloid leukemia; Incidence; Registration completeness; Validation studies

Indexed keywords

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; DENMARK; HUMAN; MEDICAL RECORD; PREDICTIVE VALUE; SEX RATIO; SWEDEN; UNITED STATES;

EID: 84884132931     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S48411     Document Type: Article

References (26)

1. The Danish Acute Leukemia Group. [Annual Leukemia Report]. Århus: ALG; 2012. Danish.
2. Juliusson G, Lazarevic V, Hörstedt AS, Hagberg O, Höglund M. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012;119(17):3890-3899.
3. Estey E. Do commonly used clinical trial designs reflect clinical reality? Haematologica. 2009;94(10):1435-1439.
4. Tsimberidou AM, Estey E. Relevance of clinical trials in acute myeloid leukaemia. Hematol Oncol. 2008;26(3):182-183.
5. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancertreatment trials. N Engl J Med. 1999;341(27):2061-2067.
6. Sørensen HT, Lash TL, Rothman KJ. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology. 2006;44(5):1075-1082.
7. Sørensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996;25(2):435-442.
8. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
9. Statistics Denmark. Population and elections. Available from: http://www.statbank.dk/statbank5a/default.asp?w=1366. Accessed June 18, 2013.
10. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
11. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(Suppl 7):22-25.
12. Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol. 2010;2: 51-56.
13. Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39(Suppl 7):72-74.
14. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101-133.
15. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-5032.
16. Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116(3):354-365.
17. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003;21(24):4642-4649.
18. Derolf AR, Kristinsson SY, Andersson TM, Landgren O, Dickman PW, Björkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood. 2009;113(16):3666-3672.
19. Surveillance Epidemiology and End Results [website on the Internet]. Available from: http://seer.cancer.gov. Accessed June 18, 2013.
20. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012;119(1):34-43.
21. Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev. 2012;21(3):474-481.
22. Lehmann S, Lazarevic V, Hörstedt A, et al. Poor outcome in secondary acute myeloid leukemia (AML): A first report from the population-based swedish acute leukemia registry. ASH Ann Meet Abstr. 2012;120:130.
23. Aström M, Bodin L, Tidefelt U. Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population. Leuk Lymphoma. 2001;41(5-6):559-570.
24. Nørgaard M, Skriver MV, Gregersen H, Pedersen G, Schønheyder HC, Sørensen HT. The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry. Eur J Cancer Prev. 2005;14(3):201-206.
25. Lamberg AL, Cronin-Fenton D, Olesen AB. Registration in the Danish Regional Nonmelanoma Skin Cancer Dermatology Database: completeness of registration and accuracy of key variables. Clin Epidemiol. 2010;2:123-136.
26. Pedersen CG, Gradus JL, Johnsen SP, Mainz J. Challenges in validating quality of care data in a schizophrenia registry: experience from the Danish National Indicator Project. Clin Epidemiol. 2012;4:201-207.